Athanasios Frydas: Is It Safe to Skip TEE Before Rhythm Control in Low Thromboembolic Risk Patients?
Athanasios Frydas, Cardiologist at the German Heart Center at Charité (DHZC), shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Excited to share our latest publication in Heart Rhythm Open.
Is it safe to omit transesophageal echocardiography (TEE) prior to elective rhythm control interventions in anticoagulated patients without risk factors for thromboembolism?
Current guidelines remain inconclusive, and clinical practice varies widely between centers.
In our retrospective analysis of 645 patients who underwent same-session transthoracic (TTE) and transesophageal echocardiography (TEE), we observed a surprisingly high prevalence of clinically relevant left atrial appendage findings—even among patients considered low risk.
Notably, left atrial strain emerged as the strongest parameter associated with thromboembolic substrate.
These findings suggest that assessing left atrial cardiomyopathy using TTE could play a key role in improving patient selection for TOE necessity prior to rhythm control interventions.
Many thanks to all the coauthors for their contribution.”
Title: Transthoracic signs of left atrial cardiomyopathy predict presence of left atrial thromboembolic substrate
Authors: Athanasios Frydas, Alice Sokour, Fabian Spinka, Victor Schweiger, Hong Ran, Florian Blaschke, Henryk Dreger, Leif-Hendrik Boldt, Abdul Shokor Parwani, Gerhard Hindricks, Daniel-Armando Morris, Ingo Hilgendorf, Matthias Schneider-Reigbert
Read the Full Article on Heart Rhythm O2
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids